Comparative Clinical Analysis of Gastroenteropancreatic Neuroendocrine Carcinomas with Liver Metastasis and Primary Hepatic Neuroendocrine Carcinomas

Table 1

Main demographic, biochemical, and clinical characteristics of the 13 primary hepatic neuroendocrine carcinoma patients.

Variable	Unit	Value
Age	Years	54 (34–76)
Gender	Male	8 (61.54)
ALT	U/L	49 (15–834)
AST	U/L	65 (21–159)
HB	G/L	121 (89–152)
Albumin	G/L	38 (25–49)
ALP	U/L	139 (76–316)
GGT	U/L	90 (15–938)
CA19-9	μg/mL	18 (3–5513.72)
Location in liver	Left	3 (23.08)
PHNEC diameter	cm	5.5 (4–16)
HbsAg	Positive	2 (15.38)
Treatment	Radical operation	4 (30.77)

Data are presented as the median value (range) or absolute frequency (%). PHNECs = primary hepatic neuroendocrine carcinomas, ALT = alanine aminotransferase, AST = aspartate aminotransferase, HB = hemoglobin, ALP = alkaline phosphatase, GGT = γ-glutamyl transpeptidase, CA19-9 = carbohydrate antigen 19-9, HbsAg = hepatitis B virus surface antigen.